Quest Announces Agreement with United Natural Foods, Inc to Help Accelerate the Client’s Operational and Sustainability Goals
April 18, 2024 08:00 ET
|
Quest Resource Holding Corporation
THE COLONY, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Today, national leader in environmental waste and recycling solutions, Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), announced...
GoHealth to Announce First Quarter 2024 Results on May 9, 2024
April 18, 2024 08:00 ET
|
GoHealth, Inc.
CHICAGO, April 18, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company...
Asure Software to Announce First Quarter 2024 Financial Results on May 2, 2024
April 18, 2024 08:00 ET
|
Asure Operations
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“Asure” or the “Company”) (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (HCM) software solutions,...
Olaplex Holdings, Inc. to Report First Quarter Fiscal 2024 Financial Results on May 2nd
April 18, 2024 07:45 ET
|
Olaplex Holdings, Inc.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report first quarter fiscal 2024 financial results before the market opens on...
JD.com Announces Updates of Its Share Repurchase Program
April 18, 2024 07:30 ET
|
JD.com, Inc.
BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and...
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
April 18, 2024 07:30 ET
|
Benitec Biopharma Inc.
-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements...
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 18, 2024 07:30 ET
|
TG Therapeutics, Inc.
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating...
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
April 18, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
April 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
JD.com Files Its Annual Report on Form 20-F
April 18, 2024 07:15 ET
|
JD.com, Inc.
BEIJING, April 18, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and...